- Home
- BXC vs ZVRA Comparison
BXC vs ZVRA Comparison
Compare BXC & ZVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BXC | ZVRA |
|---|---|---|
| Founded | 2004 | 2006 |
| Country | United States | United States |
| Employees | 1700 | N/A |
| Industry | Wholesale Distributors | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 458.5M | 472.9M |
| IPO Year | 2004 | 2015 |
Fundamental Metrics
Financial Performance| Metric | BXC | ZVRA |
|---|---|---|
| Price | $48.62 | $10.06 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 5 |
| Target Price | ★ $71.50 | $23.00 |
| AVG Volume (30 Days) | 69.0K | ★ 712.5K |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 159.21 |
| EPS | 0.02 | ★ 1.35 |
| Revenue | N/A | ★ $106,470,000.00 |
| Revenue This Year | $5.04 | $37.27 |
| Revenue Next Year | $5.09 | $53.42 |
| P/E Ratio | $2,602.75 | ★ $7.46 |
| Revenue Growth | N/A | ★ 350.91 |
| 52 Week Low | $44.78 | $7.16 |
| 52 Week High | $88.30 | $13.16 |
Technical Indicators
Market Signals| Indicator | BXC | ZVRA |
|---|---|---|
| Relative Strength Index (RSI) | 34.03 | 52.59 |
| Support Level | $44.78 | $8.25 |
| Resistance Level | $74.73 | $11.07 |
| Average True Range (ATR) | 2.82 | 0.41 |
| MACD | -0.63 | -0.05 |
| Stochastic Oscillator | 9.16 | 39.32 |
Price Performance
Historical ComparisonAbout BXC Bluelinx Holdings Inc.
BlueLinx Holdings Inc is engaged in the wholesale distribution of residential and commercial building products. Its business products are split into two categories: Structural products include items such as lumber, plywood, oriented strand board, rebar, and remesh, and Specialty products include items such as engineered wood, siding, millwork, outdoor living, specialty lumber and panels, and industrial products. The company's operations are carried out throughout the United States.
About ZVRA Zevra Therapeutics Inc.
Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.